Opthea Limited is a biologics drug developer for ophthalmic diseases. The Company develops therapies for diabetic macular edema, corneal neovascularization and transplantation, and dry eye disease. Opthea serves patients and healthcare providers in Australia.
more
Refresh
Request Primer
No publications yet
No AI primers are available right now. Create one using Smartkarma AI.